Cargando…
Metabolic subtype reveals potential therapeutic vulnerability in acute promyelocytic leukaemia
Autores principales: | Sung, Ji‐Yong, Yun, Woobin, Kim, Hyun‐Young, Kim, Hee‐Jin, Choi, Jong Rak, Kim, Sun‐Hee, Jung, Chul Won, Lee, Seung‐Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270575/ https://www.ncbi.nlm.nih.gov/pubmed/35808815 http://dx.doi.org/10.1002/ctm2.964 |
Ejemplares similares
-
Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia
por: Kim, Borahm, et al.
Publicado: (2020) -
Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017) -
Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era
por: Xu, Zheng-Li, et al.
Publicado: (2020) -
Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation
por: Lee, Hee-Jeong, et al.
Publicado: (2013) -
Role of the promyelocytic leukaemia protein in cell death regulation
por: Salomoni, P, et al.
Publicado: (2012)